Search

Your search keyword '"Saab A"' showing total 779 results

Search Constraints

Start Over You searched for: Author "Saab A" Remove constraint Author: "Saab A" Topic female Remove constraint Topic: female
779 results on '"Saab A"'

Search Results

1. What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature.

2. Ischial osteochondroma as an unusual source of pregnancy-related sciatic pain: a case report.

3. Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer

4. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico

5. Parahippocampal latrophilin-2 (ADGRL2) expression controls topographical presubiculum to entorhinal cortex circuit connectivity

6. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

7. Accuracy and Safety of 1,055 Transjugular Liver Biopsies in Postliver Transplant Patients.

8. History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites

9. Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program

10. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.

11. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

12. Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

13. Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance

14. Recurrent Episodes of Diffuse Alveolar Hemorrhage in Systemic Sclerosis 30 Days Apart

15. Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

16. Rapid calibration of an intracortical brain-computer interface for people with tetraplegia.

17. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life

18. Overall Survival and Clinical Characteristics of BRCA‐Associated Cholangiocarcinoma: A Multicenter Retrospective Study

19. Incidence of abnormal liver biochemical tests in hyperthyroidism

20. A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

21. The impact of race and ethnicity on mortality and healthcare utilization in alcoholic hepatitis: a cross-sectional study

22. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101

23. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.

24. A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

25. A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C

26. Treating fibrosing cholestatic hepatitis C with sofosbuvir and ribavirin: a matched analysis

27. Effects of Clostridium difficile Infection in Patients With Alcoholic Hepatitis

28. Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine‐based therapy with or without bevacizumab

29. Should Combination Chemotherapy Serve as the Backbone in Clinical Trials of Advanced Pancreatic Cancer?

30. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study

31. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.

32. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation

33. Awareness of Kidney Disease and Relationship to End-stage Renal Disease and Mortality

34. Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program

35. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients.

36. A role for calcium-permeable AMPA receptors in synaptic plasticity and learning.

37. Comparison of chlorhexidine and alcohol‐based antisepsis on the paralumbar fossa in cattle

38. Psychosocial screening in a pediatric diabetes clinic: Adolescents' and mothers' perspectives

39. Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin

40. Tucatinib: an investigational novel therapeutic agent for the treatment of HER-2 colorectal cancer

41. Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study

42. Cohort profile: biological pathways of risk and resilience in Syrian refugee children (BIOPATH)

43. Mechanic Hands/Hiker Feet in a Patient With Amyopathic Dermatomyositis and Interstitial Lung Disease

44. Ischial osteochondroma as an unusual source of pregnancy-related sciatic pain: a case report

45. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

46. Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study

47. Osteoclast-Like Giant Cell Tumors of the Pancreas

48. First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study

49. Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

50. Lebanese University Students and COVID-19: A Survey on their Related-Knowledge, Practice, and Behaviors

Catalog

Books, media, physical & digital resources